サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1303634

生物学的インプラント市場：製品別（同種移植片、自家移植片、異種移植片）、投与形態別（注射、外科）、用途別-2023-2030年の世界予測

Biological Implants Market by Product (Allografts, Autografts, Xenografts), Mode of Administration (Injectable, Surgical), Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
生物学的インプラント市場：製品別（同種移植片、自家移植片、異種移植片）、投与形態別（注射、外科）、用途別-2023-2030年の世界予測
出版日: 2023年06月12日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生物学的インプラントの世界市場は、2023年に337億3,000万米ドル、CAGR 21.34%で大幅な成長が予測され、2030年には1,308億4,000万米ドルという驚異的な規模に達する見込みです。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の生物学的インプラント市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.生物学的インプラントの世界市場規模および予測は？

2.予測期間中、世界の生物学的インプラント市場を形成するCOVID-19の阻害要因と影響は？

3.生物学的インプラントの世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.生物学的インプラントの世界市場における競争戦略は？

5.生物学的インプラントの世界市場における技術動向と規制の枠組みは？

6.生物学的インプラントの世界市場における主要ベンダーの市場シェアは？

7.生物学的インプラントの世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 正確なインプラント外科手術の大幅な進歩
      • 高齢化人口の増加と整形外科疾患や脊椎疾患などの疾患の発生
      • 美容インプラントに対する意識の高まり
    • 抑制要因
      • 生産コストが高い
    • 機会
      • 3Dプリンティングやレーザー技術などの技術革新
      • 再生医療と組織工学の進歩
    • 課題
      • わずかな払い戻しの問題
  • 市場動向
  • COVID-19の累積的な影響
  • ロシア・ウクライナ紛争の累積的影響
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み
  • 顧客のカスタマイズ

第6章 生物学的インプラント市場：製品別

  • 同種移植片
  • 自家移植片
  • 異種移植片

第7章 生物学的インプラント市場管理モード別

  • 注射可能
  • 外科的

第8章 生物学的インプラント市場：用途別

  • 心臓血管インプラント
  • 整形外科用インプラント
  • 軟組織インプラント

第9章 南北アメリカの生物学的インプラント市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の生物学的インプラント市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの生物学的インプラント市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. BIOLOGICAL IMPLANTS MARKET RESEARCH PROCESS
  • FIGURE 2. BIOLOGICAL IMPLANTS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 5. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2022 VS 2030 (%)
  • FIGURE 6. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 7. BIOLOGICAL IMPLANTS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 8. BIOLOGICAL IMPLANTS MARKET DYNAMICS
  • FIGURE 9. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 10. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 16. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 17. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. BIOLOGICAL IMPLANTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. BIOLOGICAL IMPLANTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 5. BIOLOGICAL IMPLANTS MARKET SIZE, BY ALLOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 6. BIOLOGICAL IMPLANTS MARKET SIZE, BY AUTOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOLOGICAL IMPLANTS MARKET SIZE, BY XENOGRAFTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOLOGICAL IMPLANTS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOLOGICAL IMPLANTS MARKET SIZE, BY SURGICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOLOGICAL IMPLANTS MARKET SIZE, BY CARDIOVASCULAR IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. BIOLOGICAL IMPLANTS MARKET SIZE, BY ORTHOPEDIC IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOLOGICAL IMPLANTS MARKET SIZE, BY SOFT TISSUE IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM BIOLOGICAL IMPLANTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. BIOLOGICAL IMPLANTS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 143. BIOLOGICAL IMPLANTS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 144. BIOLOGICAL IMPLANTS MARKET LICENSE & PRICING
目次
Product Code: MRR-ED54C46E8D72

The Global Biological Implants Market is forecasted to grow significantly, with a projected USD 33.73 billion in 2023 at a CAGR of 21.34% and expected to reach a staggering USD 130.84 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Biological Implants Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Biological Implants Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Allografts, Autografts, and Xenografts. The Autografts is projected to witness significant market share during forecast period.

Based on Mode of Administration, market is studied across Injectable and Surgical. The Injectable is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiovascular Implants, Orthopedic Implants, and Soft Tissue Implants. The Soft Tissue Implants is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.75% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Biological Implants Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biological Implants Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biological Implants Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biological Implants Market?

4. What is the competitive strategic window for opportunities in the Global Biological Implants Market?

5. What are the technology trends and regulatory frameworks in the Global Biological Implants Market?

6. What is the market share of the leading vendors in the Global Biological Implants Market?

7. What modes and strategic moves are considered suitable for entering the Global Biological Implants Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biological Implants Market, by Product, 2022 vs 2030
  • 4.3. Biological Implants Market, by Mode of Administration, 2022 vs 2030
  • 4.4. Biological Implants Market, by Application, 2022 vs 2030
  • 4.5. Biological Implants Market, by Region, 2022 vs 2030

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Significant advancement in precise implant surgical procedures
      • 5.1.1.2. Increasing aging population coupled with instances of diseases such as orthopedic and spinal disorders
      • 5.1.1.3. Rising awareness of cosmetic implants
    • 5.1.2. Restraints
      • 5.1.2.1. High production cost
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological innovations such as 3D printing and laser technology
      • 5.1.3.2. Advancements in regenerative medicine and tissue engineering
    • 5.1.4. Challenges
      • 5.1.4.1. Scant reimbursement issues
  • 5.2. Market Trends
  • 5.3. Cumulative Impact of COVID-19
  • 5.4. Cumulative Impact of Russia-Ukraine Conflict
  • 5.5. Cumulative Impact of High Inflation
  • 5.6. Porter's Five Forces Analysis
    • 5.6.1. Threat of New Entrants
    • 5.6.2. Threat of Substitutes
    • 5.6.3. Bargaining Power of Customers
    • 5.6.4. Bargaining Power of Suppliers
    • 5.6.5. Industry Rivalry
  • 5.7. Value Chain & Critical Path Analysis
  • 5.8. Regulatory Framework
  • 5.9. Client Customization

6. Biological Implants Market, by Product

  • 6.1. Introduction
  • 6.2. Allografts
  • 6.3. Autografts
  • 6.4. Xenografts

7. Biological Implants Market, by Mode of Administration

  • 7.1. Introduction
  • 7.2. Injectable
  • 7.3. Surgical

8. Biological Implants Market, by Application

  • 8.1. Introduction
  • 8.2. Cardiovascular Implants
  • 8.3. Orthopedic Implants
  • 8.4. Soft Tissue Implants

9. Americas Biological Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Biological Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Biological Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing